This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing paltusotine from Crinetics and the PATHFNDR-1 and 2 trials in acromegaly.
Ticker(s): CRNXWho's the expert?
Institution: University of Michigan
- Emeritus Professor of Endocrinology at the University of Michigan.
- Original investigator on paltusotine studies.
- Previously served as a Co-director of University of Michigan's Pituitary Center and followed 40-60 patients with acromegaly per year.
Interview GoalDiscuss the outlook on the pivotal PATHFNDER trials and how paltusotine might fit into the treatment algorithm
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
